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OBJECTIVE — Gestational diabetes is a risk factor for large-for-gestational-age (LGA) new-
borns, but many LGA babies are born to mothers with normal glucose tolerance. We aimed to
clarify the association of maternal glycemia across the whole distribution with birth weight and
risk of LGA births in mothers with normal glucose tolerance.
RESEARCH DESIGN AND METHODS — We undertook a population-based gesta-
tional diabetes screening in an urban area of Hungary in 2002–2005. All singleton pregnancies
of mothers 18 years of age, without known diabetes or gestational diabetes (World Health
Organization criteria) and data on a 75-g oral glucose tolerance test at 22–30 weeks of gestation,
wereincluded(n3,787,78.9%ofthetargetpopulation).LGAwasdeterminedasbirthweight
greater than the 90th percentile using national sex- and gestational age–speciﬁc charts.
RESULTS — Mean  SD maternal age was 30  4 years, BMI was 22.6  4.0 kg/m
2, fasting
blood glucose was 4.5  0.5 mmol/l, and postload glucose was 5.5  1.0 mmol/l. The mean
birth weight was 3,450  476 g at 39.2  1.2 weeks of gestation. There was a U-shaped
association of maternal fasting glucose with birth weight (Pcurve  0.004) and risk of having an
LGA baby (lowest values between 4 and 4.5 mmol/l, Pcurve  0.0004) with little change after
adjustments for clinical characteristics. The association of postload glucose with birth weight
(P  0.03) and the risk of an LGA baby (P  0.09) was weaker and linear.
CONCLUSIONS — Bothlowandhighfastingglucosevaluesat22–30weeksofgestationare
associated with increased risk of an LGA newborn. We suggest that the excess risk related to low
glucosereﬂectstheincreaseduseofnutrientsbyLGAfetusesthatalsoaffectsthemothers’fasting
glucose.
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T
he presence of a large fetus (either
deﬁnedbyaweightcutofforaslarge
for gestational age [LGA]) is associ-
ated with multiple risks for both the
mother and the newborn. Short-term
risks include a two- to threefold increase
in intrauterine death rate, a higher prob-
ability of operative delivery and several
neonatal morbidities (e.g., shoulder dys-
tocia and brachial plexus injuries), and
increased risk of maternal injuries (i.e.,
perineal laceration). There are also long-
term risks for the newborn, such as dia-
betes later in life, obesity, and the
development of metabolic syndrome (1).
Maternaluncontrolledpregestationaldia-
betesandgestationaldiabetesmellitusare
important risk factors for macrosomia
and LGA newborns (1,2), and evidence
from randomized controlled trials on the
treatment of gestational diabetes mellitus
supports a causal link between maternal
hyperglycemia and risk of macrosomia
(3,4).
Recently, some reports have raised
the possibility that the association of fast-
ingglucoseand2-hpostloadglucosewith
birth weight and risk of macrosomia may
actually be U-shaped such that both high
and low levels of maternal glucose are re-
lated to elevated risk of having large ba-
bies (5–7). To date, however, evidence to
support this curvilinear association is
weak. The largest observational study ad-
dressing this question, the Hyperglyce-
mia and Adverse Pregnancy Outcome
(HAPO) study, was unable to prove any
signiﬁcant deviation from linearity in the
association between fasting and postload
glucose and the risk of LGA babies. How-
ever, in this multicenter study the level of
signiﬁcance was corrected for multiple
testing potentially, increasing risk of false
null ﬁndings (8). Most other population-
based studies did not formally test non-
linearity in the blood glucose-
macrosomia association (5–7,9–15).
Moreover, many studies were based on
nonfasting maternal glucose measure-
ments, which allow analysis of the high
endoftheglucosedistributionbutcannot
detect any true effect of low glucose levels
on the risk of macrosomia. To clarify the
associationbetweenmaternalglucoseand
newborn size, we set out to investigate in
detail the association of fasting and 2-h
postload glucose with birth weight and
the risk of LGA newborns in women with
normal glucose tolerance drawn from a
general population.
RESEARCH DESIGN AND
METHODS— In 1999 a universal,
population-based screening program for
gestational diabetes mellitus was
launchedattheSzentImreTeachingHos-
pital in Budapest, Hungary. Screening
was performed using a 75-g oral glucose
tolerancetest(OGTT)accordingtoWorld
Health Organization criteria (16). The
program was approved by the Szent Imre
Hospital Ethics Committee. The institute
is located in Budapest and serves an ur-
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the ascertainment rate was 99% of all
pregnantwomendeliveredinthehospital
(17,18).
The screening database captured
5,335 pregnancies between 1 January
2002 and 30 April 2005. Our target pop-
ulation did not include women aged 18
years at the time of delivery (n  8),
women with twin pregnancies (n  115),
or women with known pregestational di-
abetes or gestational diabetes mellitus
(n  411), leaving a total of 4,801 preg-
nancies for further analysis. We excluded
641 women with an early or late OGTT
(22 or 30 weeks of gestation at the
time of analysis), 45 women because of
missing birth weight data or delivery be-
fore24weeksofgestation,266becauseof
missing or incomplete blood glucose
data, and 62 because of missing data on
covariates. Thus, the ﬁnal analytic sample
consisted of 3,787 women (78.9% of the
women in the target population).
Measurements
All 75-g OGTTs were performed in the
morning hours (before 10 A.M.) between
22 and 30 weeks of gestation. Women
were instructed to follow an unrestricted
diet for at least 3 days before the test and
to come for the investigation after at least
8 h of fasting. After the collection of fast-
ing blood samples, women were asked to
drink 75 g of anhydrous glucose in 250–
300 ml of water. Blood samples, also
taken 2 h after the glucose load, were col-
lected into ﬂuoride-containing tubes. Ve-
nous plasma glucose was measured in the
central laboratory of the hospital using a
glucose-oxidase–based method. Gesta-
tional diabetes mellitus was diagnosed if
either the fasting venous plasma glucose
was 7.0 mmol/l or the 2-h postload ve-
nous plasma glucose was 7.8 mmol/l.
Data on birth weight and sex of the
newborn were extracted from the dis-
charge documentation. LGA was deter-
mined as a birth weight greater than the
90th percentile on sex- and gestational
age–speciﬁc national charts (19).
Gestational age was primarily based
on the date of the last menstrual period
andwassubstitutedbytheresultofaﬁrst-
trimester ultrasound examination
(8–12 weeks of gestation) if informa-
tion on the last menstrual period was
missing or if there was a 2-week dis-
crepancy between the two estimates.
At the time of the OGTT, anthropo-
metricmeasurements(heightandweight)
were performed and BMI was calculated.
Systolic and diastolic blood pressures
were determined by a trained nurse using
a standard mercury sphygmomanometer.
Themeanarterialpressurewascalculated
as (2  diastolic blood pressure  sys-
tolic blood pressure)/3. After delivery a
detailed questionnaire was completed
during a face-to-face interview by a
trained researcher (A.P.). Family history
of diabetes among ﬁrst-degree relatives,
age of the mother, smoking status during
pregnancy (yes or no), ethnicity (Cauca-




SD for continuous variables and percent-
ages for categorical variables. After inves-
tigation of crude frequencies of LGA
babies according to fasting and 2-h post-
load glucose categories, we computed bi-
nary logistic regression models with LGA
as the outcome and glucose categories as
dummy variables (fasting glucose 3.5,
3.51–4.0, 4.01–4.5, 4.51–5.0, 5.01–5.5,
and 5.51 mmol/l and 2-h postload glu-
cose 4.0, 4.01–4.8, 4.81–5.6, 5.61–
6.4, 6.41–7.2, and 7.21 mmol/l), the
third category being the reference cate-
gory in both analyses. Odds ratios (ORs)
and 95% CIs were adjusted for ethnicity,
parity of the mother, and sex of the new-
born (model 1) and then were further ad-
justed for maternal age, BMI, smoking,
family history of diabetes, gestational age
at the OGTT, mean arterial blood pres-
sure, and height (model 2). Similar gen-
eralized linear models using logit link
were computed with continuous fasting
and postload blood glucose and their
squared terms (to test for nonlinearity) as
independent variables instead of glucose
categories and to estimate probabilities
and their CIs on continuous glucose
scales.
Furtheranalysesapplyinggenerallin-
ear modeling examined associations of
maternal glucose with birth weight de-
scribing crude and adjusted birth weights
(and SEM) in the above glucose catego-
ries. Then we applied similar models to
test for linear and curvilinear trends in
these associations with linear and qua-
dratic glucose terms (as required). We es-
timated birth weights from these models
afteradjustingforcovariates(model1and
model2)asdescribedabove.Allstatistical
analyses were done using SPSS for Win-
dows 16.0. Two-tailed P  0.05 was con-
sidered statistically signiﬁcant.
RESULTS— Characteristics of the
mothers and newborns and pregnancy
outcomesaresummarizedinTable1.The
mean age of the subjects was 29.7 years,
and the mean fasting and 2-h postload
glucose levels were 4.5 and 5.5 mmol/l,
respectively.Therewere12stillbirthsand
no maternal deaths in the target
population.
Risk of LGA newborns according to
the fasting and 2-h postload glucose
levels
The frequency of LGA newborns across
the predeﬁned fasting and postload glu-
cose categories is shown in Table 2. Fast-
ing blood glucose showed a nonlinear
relationship with the risk of LGA: com-
paredwiththereferencegroup(4.01–4.5
mmol/l) both lower and higher maternal
fastingglucoselevelswereassociatedwith
increased risk (Table 2). The curvilinear
association was statistically signiﬁcant in
amodelsimultaneouslyincludingcontin-
uous fasting glucose and its square irre-
spective of adjustments (Pcurve  0.004
for model 1 and Pcurve  0.04 for model
2) (Fig. 1A).
Postloadglucoseshowedaweakeras-
sociation with the risk of LGA and only
thehighestmaternalglucosecategorywas
related to elevated risk in a model ad-
justed for sex, ethnicity, and parity. How-
ever, this association was attenuated and
became nonsigniﬁcant after further ad-
justments (Table 2). In the logistic regres-
sion analysis using continuous glucose
valuesaspredictors,thesquaredtermwas
nonsigniﬁcant(Pcurve0.46)andthelin-
ear association between postload glucose
and the risk of LGA was weak and only
borderlinesigniﬁcant(OR1.08[95%CI
0.99–1.17], per 1 mmol/l increase in
postload glucose, P  0.08 for model 1;
1.07 [0.98–1.17], per 1 mmol/l in-
crease in postload glucose, P  0.13 for
model 2).
Birth weight according to the fasting
and 2-h postload glucose levels
The crude birth weight showed a U-
shaped association with the predeﬁned
fasting glucose categories with the lowest
values in the third group (4.01–5.0
mmol/l) and higher values at both ends of
theglucosedistribution(Table3).Theas-
sociation between continuous maternal
fastingglucoselevelsandbirthweightfol-
lowed a quadratic function; the lowest
birth weight values were between 4 and
4.5 mmol/l (Pcurve  0.0001 for model
1) (Fig. 1B). This association was robust
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0.01 for model 2; detailed data not
shown).
There was a linear association be-
tween 2-h postload glucose and birth
weight (P  0.03 for model 1) with no
evidence of curvilinearity (Table 3, Fig.
1C). Again, further adjustment had little
effectonthemodels(P0.002formodel
2, detailed data not shown).
CONCLUSIONS
Short summary
In this population-based screening pro-
gram of gestational diabetes mellitus us-
ing a 75-g OGTT, the risk of LGA
newborns was nonlinearly related to fast-
ing glucose levels among predominantly
Caucasian women residing in an urban
areaofHungary.Increasedriskwasfound
at both ends of the maternal fasting glu-
cose distribution. The association be-
tween fasting glucose and birth weight of
the newborns was similarly U-shaped
with the lowest values found between 4
and 4.5 mmol/l. In contrast, 2-h postload
glucose showed only a borderline rela-
tionship with the risk of LGA and the as-
sociationwithbirthweightwaslinearand
weaker than that for fasting glucose.
Comparison with other studies
Although there are several population-
based screening studies for gestational di-
abetes mellitus, only a few reported
fasting glucose values at the time of the
screening (5,7–11,13,14,20). This is not
surprising because the widely accepted
American Diabetes Association Position
Statement generally recommends pre-
screening with a glucose challenge test
that is performed irrespective of fasting
status.AnOGTTisrecommendedonlyin
the case of an abnormal result (21).
However, at least six previous studies
haddataonmaternalfastingglucose.Two
of the medium-sized studies did not re-
port tests for nonlinearity or risk for cat-
egoricalglucosegroupsandthuswerenot
informative regarding the U-shaped asso-
ciation between fasting glucose and the
risk of LGA (9,20). Two other studies re-
ported formal tests of nonlinearity for the
fasting glucose–LGA relationship: One
showed no clear inﬂection point for these
associationsbutobservedanelevatedrisk
in the lowest glucose category (7). The
HAPO study found no signiﬁcant devia-
tion from linearity (8). Despite its very
large sample size, some circumstances
should be mentioned that might have re-
duced sensitivity to observe elevated LGA
atthelowendofmaternalfastingglucose.
First, the HAPO study involved a multi-




certain ethnicities. Second, because of the
excessive number of outcomes investi-
gated, the HAPO investigators had to cor-
rect their P values for multiple testing,
which may have increased the risk of a
type I error (rejecting a null hypothesis
when it is true). Third, in the categorical
analysis of fasting glucose, their lowest
group was deﬁned as glucose levels 4.2
mmol/l, which does not differentiate the
threelowestcategoriesusedinthepresent
analysis (8). Furthermore, when we com-
bined the ﬁrst three groups into one cat-
egory in our data, the relationship
Table 1—Characteristics of study subjects and their newborns
% Value
Maternal
Age (years) 29.7  4.2 (27.1–32.3)
BMI (kg/m
2)* 25.2  4.0 (22.4–27.0)
Caucasian (%) 98.4
Mean arterial pressure (mmHg)* 81.4  9.1 (73.3–86.7)
Blood glucose (mmol/l)*
Fasting 4.5  0.5 (4.2–4.8)
2-h 5.5  1.0 (4.8–6.2)
Length of gestation at the time of OGTT (weeks) 25.5  1.8 (24–27)
Any smoking during pregnancy (%) 4.4
Diabetes among ﬁrst-degree relatives (%) 12.8
Nulliparous (%) 56.9
Newborn
Gestational age at delivery (weeks) 39.2  1.2 (39–40)
Birth weight (g) 3,450  476 (3,150–3,750)
Male sex (%) 51.6
LGA (%)† 16.5
Data are % or means  SD (interquartile range). n  3,787. *Age, BMI, and mean arterial pressure were
obtained at the OGTT (22–30 weeks of gestation). †LGA was determined as a birth weight greater than the
90th percentile on sex- and gestational age–speciﬁc national charts.
Table 2—Risk of LGA newborns by fasting and 2-h postload glucose categories in 3,787
singleton pregnancies
LGA/total number % LGA* Model 1† Model 2‡
Fasting glucose
categories
3.5 mmol/l 23/137 16.8 1.28 (0.79–2.06) 1.33 (0.81–2.19)
3.51–4.0 mmol/l 84/489 17.2 1.33 (1.003–1.77) 1.38 (1.03–1.86)
4.01–4.5 mmol/l 178/1,300 13.7 1 (referent) 1 (referent)
4.51–5.0 mmol/l 230/1,357 16.9 1.27 (1.03–1.57) 1.25 (1.00–1.56)
5.01–5.5 mmol/l 84/417 20.1 1.53 (1.15–2.05) 1.36 (1.00–1.83)
5.51 mmol/l 25/87 28.7 2.45 (1.50–4.03) 1.84 (1.08–3.15)
2-h postload glucose
categories
4.0 mmol/l 42/275 15.3 1.00 (0.69–1.45) 1.02 (0.69–1.50)
4.01–4.8 mmol/l 120/710 16.9 1.15 (0.89–1.49) 1.16 (0.88–1.51)
4.81–5.6 mmol/l 164/1,106 14.8 1 (referent) 1 (referent)
5.61–6.4 mmol/l 165/957 17.2 1.19 (0.94–1.51) 1.21 (0.95–1.55)
6.41–7.2 mmol/l 94/550 17.1 1.18 (0.90–1.56) 1.19 (0.89–1.59)
7.21 mmol/l 39/189 20.6 1.50 (1.02–2.23) 1.43 (0.95–2.17)
Data are ORs (95% CI). *LGA was determined as a birth weight greater than the 90th percentile on sex-
andgestationalage–speciﬁcnationalcharts.†Model1isadjustedforethnicity,parityofthemother,and
sex of the newborn. ‡Model 2 is adjusted for ethnicity, parity of the mother, sex of the newborn,
maternalage,BMI,smoking,familyhistoryofdiabetes,gestationalageattheOGTT,meanarterialblood
pressure, and height.
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LGA seemed to be linear (data available
on request). There is a further study that
reportsonmacrosomia(birthweightover
acertaincutoffvalue)asafunctionoffast-
ing glucose levels and suggests no devia-
tion from linearity (5).
Literaturedataarenotmuchmorede-
tailed regarding the relationship between
fasting glucose and birth weight. At least
fourstudiesreportedpositivecorrelations
with various strengths between birth
weightandfastingglucosewithouttesting
for nonlinearity (11,13,14,20). One of
these investigated the shape of the fasting
glucose–birth weight relationship and
found that the linear association between
fasting glucose and birth weight holds
only for the middle ranges of the glucose
distribution (7).
We did not observe a U-shaped as-
sociation between postload glucose and
size of newborn, and the linear trend
found was only suggestive. In previous
studies, a linear relationship between
2-h postload glucose and the risk of
LGA or macrosomia was a frequent ob-
servation before adjustment for covari-
ates (5,7–10,12,15). Whereas some
studies reported a strong linear rela-
tionship after several adjustments (8,9),
others, similarly to us, found weak or
nonsigniﬁcant relationships between
postload glucose and the risk of LGA or
macrosomia (5,10). In our study, this
observation was related to mothers with
normal glucose tolerance; that is, those
at the low and moderate but not at the
Figure 1—Estimated probability of an LGA newborn by continuous fasting blood glucose (A) and estimated birth weight according to continuous
fasting (B) and 2-h postload (C) glucose levels adjusted for ethnicity, parity of the mother, and sex of the newborn. Error bars show 95% CI around
the estimates.
Table 3—Birth weight by fasting and 2-h postload glucose categories in 3,787
singleton pregnancies
Crude birth weight (g) Model 1* Model 2†
Fasting glucose
categories
3.5 mmol/l 3,496 (3,417–3,576) 3,525 (3,447–3,604 3,529 (3,451–3,606)
3.51–4.0 mmol/l 3,447 (3,405–3,489) 3,477 (3,435–3,520) 3,491 (3,449–3,532)
4.01–4.5 mmol/l 3,397 (3,371–3,423) 3,423 (3,396–3,450) 3,437 (3,410–3,464)
4.51–5.0 mmol/l 3,466 (3,440–3,491) 3,492 (3,465–3,518) 3,496 (3,470–3,522)
5.01–5.5 mmol/l 3,535 (3,490–3,581) 3,553 (3,508–3,599) 3,528 (3,483–3,572
5.51 mmol/l 3,537 (3,437–3,637) 3,559 (3,461–3,657) 3,549 (3,452–3,646)
2-h postload glucose
categories
4.0 mmol/l 3,440 (3,383,3,496) 3,459 (3,403–3,515) 3,453 (3,398–3,508)
4.01–4.8 mmol/l 3,427 (3,392–3,462) 3,451 (3,416–3,487) 3,443 (3,409–3,478)
4.81–5.6 mmol/l 3,450 (3,422–3,478) 3,479 (3,449–3,508) 3,486 (3,458–3,515)
5.61–6.4 mmol/l 3,454 (3,424–3,485) 3,479 (3,448–3,511) 3,488 (3,458–3,519)
6.41–7.2 mmol/l 3,466 (3,426–3,506) 3,498 (3,457–3,538) 3,511 (3,471–3,550)
7.21 mmol/l 3,484 (3,416–3,552) 3,521 (3,453–3,588) 3,530 (3,465–3,595)
Data are means (95% CI). *Model 1 is adjusted for ethnicity, parity of the mother, and sex of the newborn.
†Model 2 is adjusted for ethnicity, parity of the mother, sex of the newborn, maternal age, BMI, smoking,
family history of diabetes, gestational age at the OGTT, mean arterial blood pressure, and height.
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distribution(glucoselevels7.8mmol/
l). In general, 2-h postload glucose
seems to be a weaker predictor of birth
weight than fasting glucose, similarly to





the maternal glucose distribution sup-
ports the Pedersen (22) hypothesis,
which suggesting that maternal hyper-
glycemia (even within the normal
range) increases the levels of fetal insu-
lin, leading to accelerated growth and
macrosomia in the fetus. We propose
fetal hyperinsulinemia as a plausible
mechanism underlying the association
between low fasting glucose and risk of
LGA newborns. Fetal insulin is proba-
bly the most important growth hor-
mone during intrauterine development,
and increases in fetal insulin levels are
related to accelerated growth (1,2). Fe-
tal hyperinsulinemia may lead to lower
maternalglucoselevelsbyincreasingfe-
toplacental siphoning of maternal glu-
cose in normoglycemic mothers (2,23).
Inlinewiththisreasoning,thereissome
evidence to show a decrease in glucose
levels as gestation progresses in women
with hyperinsulinemic newborns,
whereas glucose levels are increasing in
mothers with normoinsulinemic new-
borns (24). All the above together sug-
gest a common mechanism (fetal
hyperinsulinemia) linking lower fasting
glucose levels and the risk of LGA or
increased birth weight. Further studies
are warranted to test this hypothesis.
Study strengths and limitations
Our study beneﬁts from the universal use
of the 75-g OGTT in an ethnically homo-
geneous population as this allowed us to
reliablyexplorethelowendoftheglucose
distribution. A similar shape of the asso-
ciationwasconﬁrmedforbothcategorical
and continuous glucose levels as predic-
tors, and we were able to adjust for awide
range of known confounders of macroso-
mia in our analysis. The women who were
excluded based on missing data were more
likelytobefromethnicminoritiesandtobe
smokers, but their general characteristics
were very similar to those of the population
investigated; thus, it is unlikely that this ex-
clusion had a large effect on our ﬁndings
(supplemental data, available at http://care.
diabetesjournals.org/cgi/content/full/dc09-
1088/DC1). Although the exclusion of
women meeting the World Health Or-
ganization criteria for gestational diabe-
tes mellitus reduced the high end of the
glucose distribution, this is unlikely to
have selectively removed the smaller ba-
bies from the lowest categories or the
larger babies from the middle ranges, so
we think that our ﬁndings of a nonlinear
association of fasting glucose with birth
weight and macrosomia are valid. We
usedthelatestpublishedpercentilecharts
for the deﬁnition of LGA newborns; how-
ever, it obviously does not correspond to
our target population, given the 16.5%
rate of LGA in this study (19). This result
isinagreementwithanoverallincreasein
the prevalence of large babies worldwide
(1). We believe that a general increase in
birth weight would not invalidate our
ﬁndings on the risk of LGA and deﬁnitely
would not affect the associations found
for birth weight. However, we investi-
gated a surrogate pregnancy outcome,
and thus it remains unclear whether the
LGA babies of mothers with decreased
fasting glucose have an otherwise poor





may be improved by adding the square
of fasting glucose value to the known
predictors. Further research is needed
to determine whether our ﬁndings are
generalizable to other populations and
to examine fetal hyperinsulinemia and
other potential underlying mechanisms
for the excess risk of LGA babies among
mothers with low fasting glucose.
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